EHJ Editor-in-Chief
@ehj_ed
Followers
30,541
Following
630
Media
1,998
Statuses
2,603
Official twitter account of the European Heart Journal Editor-in-Chief. Tweets by Prof. Filippo Crea and his team. #EHJ .
Rome, Italy
Joined January 2020
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Madrid
• 1659365 Tweets
Champions
• 711131 Tweets
Bayern
• 660763 Tweets
Joselu
• 348556 Tweets
مدريد
• 224155 Tweets
Neuer
• 172326 Tweets
Vini
• 154238 Tweets
Tuchel
• 141522 Tweets
Harry Kane
• 82551 Tweets
Luka
• 81657 Tweets
FURIA ES GRAN HERMANO
• 79017 Tweets
De Ligt
• 73404 Tweets
Uruguai
• 72604 Tweets
Steve Albini
• 65650 Tweets
Kimmich
• 55304 Tweets
Joker
• 51592 Tweets
共同親権
• 50007 Tweets
#虎に翼
• 41848 Tweets
Shai
• 38382 Tweets
Jokic
• 38124 Tweets
نوير
• 37042 Tweets
Venus
• 27594 Tweets
Shaq
• 22999 Tweets
#SalvemOCavaloDeCanoas
• 22248 Tweets
DPVAT
• 21914 Tweets
アイスクリームの日
• 20083 Tweets
Soto
• 19404 Tweets
twenty one pilots
• 17828 Tweets
Talleres
• 12579 Tweets
もちづきさん
• 10225 Tweets
Pinned Tweet
Explore the latest in non-traditional risk factors in issue 45-17:
Dive into research on built environment through Google Street View, and uncover the links between syphilis and rheumatoid arthritis.
@escardio
@ESC_Journals
#EHJ
#cardiotwitter
1
4
19
Hypertension management in patients with cardiovascular comorbidities. A State-of-the-Art review just published in
#EHJ
.
@escardio
@ESC_Journals
#CardioTwitter
#hypertension
1
230
604
Takotsubo syndrome is a coronary microvascular disease: experimental evidence that abnormalities in flow regulation between the LV apex and base cause TTS.
Read more in
#EHJ
@escardio
@ESC_Journals
#CardioTwitter
#Takotsubo
6
138
530
Prevention and treatment of diuretic resistance in acute heart failure: when to use which combination of diuretics?
#HF
#diuretics
#prevention
#DAPARESIST
#cardiotwitter
@escardio
@ESC_Journals
2
176
422
News from EMMY trial: in myocardial infarction, empagliflozin improves NT-proBNP and left ventricular ejection fraction!
#myocardial
#infarction
#empaglifozin
#ehj
#cardiotwitter
@ESC_Journals
@escardio
5
145
375
This is my last Tweet as Editor-in-Chief of the EHJ: It is to say thank you and to alert you this issue on inflammation and fast track ESC papers online. Stay in touch, other Tweets will follow.
#EHJ
#ESC
#Cardiotwitter
@ESC_Journals
@escardio
21
62
367
Iron supplementation in acute heart failure: energize your life !
#cardiotwitter
@ESC_Journals
@escardio
2
137
363
Atrial septal defect in adulthood: a new paradigm for congenital heart disease. A State-of-the-Art Review in
#EHJ
@escardio
@ESC_Journals
#CardioTwitter
3
151
357
Microvascular angina: quo tendimus?
#ischaemia
#angina
#coronary
#microcirculation
#CFR
#CMD
#cardiotwitter
@escardio
@ESC_Journals
3
128
350
What were the major advances in research in interventional cardiology in 2021? The year in cardiology series will tell you:
#EHJ
@ESC_Journals
1
143
320
Statins revisited: therapeutic applications beyond lipid lowering?
Read more in EHJ:
#statin
#pleiotropiceffects
#EHJ
#cardiotwitter
@ESC_Journals
@escardio
5
106
313
Digoxin or beta-blockers for atrial fibrillation with heart failure? RATE-AF trial showing that patient and public involvement in trial can generate a robust evidence-base to guide clinical management.
#cardiotwitter
,
@ESC_Journals
,
@escardio
,
#AF
.
2
152
306
Complete aortic thrombosis in SARS-CoV-2 infection: have a look on this impressive case.
.
#cardiotwitter
,
@ESC_Journals
,
@escardio
,
#aorta
,
#thrombosis
,
#COVID19
13
107
299
New-onset atrial fibrillation prediction: the HARMS2-AF risk score.
Read more in
#EHJ
@escardio
@ESC_Journals
#CardioTwitter
#atrialfibrillation
2
120
296
It is with a heavy heart that we must announce the passing of Prof. Attilio Maseri, one of the great contributors to the history of cardiology and a mentor and friend to many.
17
62
286
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. Read more in EHJ!
@escardio
@ESC_Journals
1
117
287
New study shows that a subset of HFrEF patients without atrial fibrillation have a stroke risk equivalent to that of patients with AF who are not anticoagulated
#stroke
#heartfailure
#HF
#cardiotwitter
@ESC_Journals
@escardio
1
99
284
Mavacamten, a myosin inhibitor, is the first disease-specific treatment for obstructive hypertrophic cardiomyopathy. Read more in
#EHJ
.
#hypertrophic
#cardiomyopathy
#myosin
#cardiotwitter
@ESC_Journals
@escardio
1
108
281
What we (don’t) know about myocardial injury after COVID-19. Discover it in EHJ:
#myocardialinjury
#COVID19
#MI
#cardiotwitter
@escardio
@ESC_Journals
7
118
274
Restrictive cardiomyopathy: definition and diagnosis. All you ever wanted to know in EHJ...
#RCM
#diagnosis
#amyloidosis
#cardiotwitter
@escardio
@ESC_Journals
2
102
256
Dapagliflozin improves cardiovascular outcomes across the spectrum of body mass index in heart failure with preserved ejection fraction: new data from DELIVER trial!
#heart
#failure
#dapaglifozin
#obesity
#ehj
#cardiotwitter
@ESC_Journals
@escardio
5
84
256
Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials in
#EHJ
@escardio
@ESC_Journals
#EHJ
#CardioTwitter
#metaanalysis
3
113
255
Popeye’s sign is uncommon but pivotal to diagnose transthyretin amyloidosis! Read
#EHJ
Cardiovascular Flashlight!
#cardiac
#amyloidosis
#EHJ
#cardiotwitter
#biceps
#tendon
#rupture
@ESC_Journals
@escardio
3
76
251
New-onset atrial fibrillation prediction: the HARMS2-AF risk score.
#AF
#lifestyle
#alcohol
#obesity
#screening
#score
#cardiotwitter
@escardio
@ESC_Journals
2
100
252
A new tool for the forgotten valve: a score to predict the risk of surgery
@escardio
#EHJ
#tricuspid
#cardiacsurgery
#HeartTeam
0
82
251
Migraine and cardiovascular disease: what cardiologists should know.
A State-of-the-Art Review just published in
#EHJ
@escardio
@ESC_Journals
#CardioTwitter
#migraine
1
88
243
The ‘10 commandments’ for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
#diabetes
#SGLT2inhibitor
#cardiotwitter
@ESC_Journals
@escardio
1
98
247
Who wants to live forever? Eugene Braunwald suggests how to live to 100 before developing clinical coronary artery disease...
#cardiotwitter
,
@ESC_Journals
,
@escardio
,
#life
,
#aging
,
#coronary
,
#cholesterol
,
#LDL
6
106
243
Heart failure drug treatment: the fantastic four!
Learn more:
#HF
#SGLT2
#ARNI
#cardiotwitter
@escardio
@ESC_Journals
2
96
243
Colchicine for cardiovascular prevention: the dawn of a new era has finally come.
#colchicine
#inflammation
#MI
#CVD
#cardiotwitter
@escardio
@ESC_Journals
1
100
237
Statin intolerance: how common is it and how do we work with patients to overcome it?
#statins
#cholesterol
#cardiotwitter
@ESC_Journals
@escardio
3
99
241
Resistant hypertension: cardiorenal protection with mineralocorticoid receptor blockade. Read more in EHJ!
#hypertension
#EHJ
#cardiotwitter
@ESC_Journals
@escardio
1
93
236
Pulmonary vascular disease in pulmonary hypertension due to left heart disease: new pathophysiologic implications stemming from a new study in the current issue.
#pulmonaryhypertension
#cardiotwitter
@ESC_Journals
@escardio
1
104
236
Empagliflozin in acute Myocardial Infarction: the EMMY trial in
#EHJ
Just released during
#ESCCongress
#myocardialinfarction
#empaglifozin
#SGLT2i
#CardioTwitter
@escardio
@ESC_Journals
4
91
230
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document
#EHJ
#cardiotwitter
@escardio
0
76
231
Evolution of the tilt test protocol for reflex syncope and autonomic dysfunction 1986–2023: faster and still accurate.
Read more in EHJ:
#syncope
#tilttest
#EHJ
#cardiotwitter
@ESC_Journals
@escardio
0
81
231
Low-dose amiodarone and risk of interstitial lung disease: the results from contemporary atrial fibrillation cohort!
#amiodarone
#lung
#disease
#cancer
#nationwide
#population
#cardiotwitter
@ESC_journals
@escardio
3
77
227
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: new meta-analysis in current EHJ issue.
#DAPT
#platelets
#PCI
#cardiotwitter
@ESC_Journals
@escardio
1
85
223
Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation. Read the latest State of the Art Review in
#EHJ
!
#exercise
#CVD
#prevention
#outcome
#cardiotwitter
@escardio
@ESC_Journals
1
72
223
Dilated cardiomyopathy: so many cardiomyopathies!Learn more in EHJ:
#DCM
#cardiotwitter
@ESC_Journals
@escardio
1
75
221
To stent or not to stent? Read the discussion about how to treat angina after ISCHEMIA trial in the last EHJ issue.
.
#stent
,
#cardiotwitter
,
@ESC_Journals
,
@escardio
.
2
91
222
Heart–brain interactions in cardiac and brain diseases: why sex matters. A State-of-the-Art Review in
#EHJ
@escardio
@ESC_Journals
#CardioTwitter
2
98
219
How should we accelerate our titration of drugs to treat heart failure? Will this reduce HF hospitalisation or mortality?
5
93
218
Care from initial diagnosis to the long term. A position paper on managing patients with acute pulmonary embolism.
0
77
219
The "ten commandments" for the 2021 ESC Guidelines on CVD prevention!
#prevention
#guidelines
#cardiotwitter
@escardio
@ESC_Journals
2
83
217
Transcatheter treatment of the tricuspid valve: current status and perspectives. A State-of-the-Art Review just published in
#EHJ
@escardio
@ESC_Journals
#CardioTwitter
@drmaisano
@PhilippLurz
0
80
216
Was Paul Wood wrong about pre-capillary pulmonary hypertension protecting against pulmonary congestion in left heart disease?
#PH
#exercise
#LHD
#cardiacoutput
#congestion
@escardio
@ESC_Journals
2
86
216
Aspirin-free antiplatelet strategies after percutaneous coronary interventions. A State-of-the-Art Review just published in
#EHJ
@escardio
@ESC_Journals
#CardioTwitter
@DFCapodanno
1
62
215
Digitalis in heart failure: declining use and ongoing outcome trials.
#EHJ
#digoxin
#HF
#AF
#trials
#outcome
#cardiotwitter
@escardio
@ESC_Journals
0
87
214
Tissue changes in reperfused myocardial infarction: the 4 stages of myocardial ischaemia and reperfusion injury can be classified.
#MI
#reperfusion
#ischemia
#cardiotwitter
@ESC_Journals
@escardio
3
78
213
Peripartum cardiomyopathy: from genetics to management. All you wanted to know in EHJ!
#PPCM
#cardiomyopathy
#heartfailure
#pregnancy
#genetics
#cardiotwitter
@escardio
@ESC_Journals
1
85
210
Microvascular resistance reserve: a reference test of the coronary microcirculation?
#physiology
#microcirculation
#MRR
#cardiotwitter
@escardio
@ESC_Journals
1
78
206
Acute heart failure represents the most frequent cause of unplanned hospital admission in patients older than 65 years. Current pharmacological treatment and perspectives are herein overviewed
#HF
#heartfailure
#cardiotwitter
@ESC_Journals
@escardio
2
89
209
BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction. Read more in EHJ!
#cardiotwitter
@ESC_Journals
@escardio
3
88
208
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials: now in EHJ
#cardiotwitter
@ESC_Journals
@escardio
3
86
204
Inflammation in acute myocardial infarction: must-read state of the art review summarizes the knowledge in the field
#inflammation
#CAD
#MI
#cardiotwitter
@ESC_Journals
@escardio
1
73
199
What cardiologists should know about sleep...
#sleep
#AF
#HF
#OSA
#CVD
#health
#cardiotwitter
@escardio
@ESC_Journals
0
75
197
Current recommendations and uncertainties for surgical treatment of infective endocarditis: a comparison of American and European cardiovascular guidelines: read more in EHJ.
@escardio
@ESC_Journals
#IE
1
74
197
The interplay between physical activity volume and cardiovascular disease: higher physical activity energy expenditure is the key!
#ischemic
#heart
#disease
#physical
#activity
#cardiotwitter
#ehj
@escardio
@ESC_Journals
2
79
193
Personalised antiplatelet therapies for coronary artery disease: what the future holds.
A State-of-the-Art Review just published in
#EHJ
@DFCapodanno
@escardio
@ESC_Journals
#CardioTwitter
#coronaryarterydisease
0
77
195
Vascular repair and regeneration in cardiometabolic diseases. A State-of-the-Art Review in
#EHJ
@ESC_Journals
@escardio
#CardioTwitter
0
81
196
Was Paul Wood wrong about pre-capillary pulmonary hypertension protecting against pulmonary congestion in left heart disease? Read more in EHJ !
@escardio
@ESC_Journals
#PH
1
68
197
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled just published in
#EHJ
#heartfailure
#CardioTwitter
@escardio
@ESC_Journals
3
62
193
SGLT2 inhibitors in heart failure: insights from plasma proteomics: read more in EHJ!
@escardio
@ESC_Journals
#SGLT2
0
66
188
Albuminuria is a marker of systemic congestion in patients with heart failure: read more in EHJ!
@escardio
@ESC_Journals
#heartfailure
0
69
192
Thrombosis and fibrinolysis in atherosclerotic cardiovascular disease: it takes two to tango!
#thrombosis
#atherosclerosis
#fibrinolysis
#risk
#cardiotwitter
@escardio
@ESC_Journals
0
71
191
In EMPEROR-Preserved trial, the real effect of empagliflozin on blood pressure!
#empaglifozin
#systolic
#pressure
#safety
#efficacy
#cardiotwitter
#EHJ
@ESC_Journals
@escardio
1
69
192
Frailty: a new vital sign in heart failure comes of age. Read more in
#EHJ
:
#frailty
#HF
#cardiotwitter
@escardio
@ESC_Journals
1
78
187
Do we need dedicated heart failure with preserved ejection fraction clinics?
Read more in
#EHJ
@escardio
@ESC_Journals
#CardioTwitter
#heartfailure
3
64
186
Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management. Read more in
#EHJ
:
#mitral
#valve
#arrhythmia
#risk
#cardiotwitter
@escardio
@ESC_Journals
1
71
187
Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure: read more in EHJ!
#SGLT2
#hyperkalaemia
#HF
#EMPEROR
#cardiotwitter
@escardio
@ESC_Journals
1
64
187
TAVI or surgical aortic valve replacement? Consider patient life expectancy first!
#cardiotwitter
@ESC_Journals
@escardio
1
64
187
Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments. Read more in EHJ!
#HFpEF
#Hypertrophic
#Fabry
#Amyloidosis
#Drug
#cardiotwitter
@ESC_Journals
@escardio
2
59
184
Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial! Discover more:
#CKD
#mortality
#dapagliflozin
#cardiotwitter
@escardio
@ESC_Journals
2
65
186
Similarities and dissimilarities in ESC and ACC/AHA guidelines in surgical treatment of patients with infective endocarditis!
#infective
#endocarditis
#ehj
#cardiotwitter
@escardio
@ESC_Journals
0
66
187
Fate of the unoperated ascending thoracic aortic aneurysm: three-decade experience from the Aortic Institute at Yale University. Read more in
#EHJ
@escardio
@ESC_Journals
#CardioTwitter
0
65
179
The cardiovascular effects of sodium–glucose co-transporter-2 inhibitors with concomitant mineralocorticoid receptor antagonist use in heart failure. Read the latest meta-analysis in
#EHJ
.
#heartfailure
#mortality
#cardiotwitter
@ESC_Journals
@escardio
0
80
183
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Read morein EHJ!
@escardio
@ESC_Journals
1
65
185
Rhythm control in asymptomatic "early" atrial fibrillation: birth of a new paradigm? Read the latest editorial in EHJ!
#AF
#therapy
#cardioversion
#ablation
#cardiotwitter
@escardio
@ESC_Journals
0
75
183
Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy. A State of the Art Review in
#EHJ
@escardio
#CardioTwitter
#aorticstenosis
#TAVI
1
58
181
The ‘true’ natural history of ascending thoracic aortic aneurysm. Read the three-decade experience from the Aortic Institute at Yale University in
#EHJ
.
#aortic
#aneurysm
#cardiotwitter
@ESC_Journals
@escardio
.
1
65
179
Defining new treatment strategies in Takotsubo syndrome: the news by
#EHJ
Editorial!
#microvascula
#angina
#takotsubo
#cardiotwitter
#EHJ
@ESC_Journals
@escardio
0
57
181
Current evidence on personalized and differential use of anticoagulants, platelet inhibitors, and devices: learning from EHJ State of the Art Review!
#antithrombotic
#treatment
#device
#cardiotwitter
#EHJ
@escardio
@ESC_Journals
0
56
174
Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial just published in
#EHJ
:
#DM
#PCI
#CVD
#cardiotwitter
@ESC_Journals
@escardio
1
70
177
Effects of lifelong endurance training on coronary atherosclerosis: surprising results presented just now at
#ACC
.23. Read here:
#EHJ
#atherosclerosis
#athletes
#cardiotwitter
@ESC_Journals
@escardio
@ACCinTouch
3
73
166
Keep your rhythm during rotational night work shifts!
#nightshift
#atrialfibrillation
#CAD
#risk
#cardiotwitter
@escardio
@ESC_Journals
1
74
175
Left bundle branch area pacing in perspective... Discover more in EHJ!
#LBBB
#pacing
#CSP
#cardiotwitter
@escardio
@ESC_Journals
1
64
170
What about PCSK9 inhibition for acute arterial events ? new editorial paper related to the FOURIER trial.
#LDL
,
#cholesterol
,
#AMI
,
#cardiotwitter
,
@ESC_Journals
,
@escardio
0
53
169
An excellent editorial covering the recently published FORECAST trial - FFR-CT in assessment and management of stable chest pain.
@NickCurzen
@ESC_Journals
@escardio
1
62
173
Is the "tilt test " still alive? Tilt testing remains a valuable asset! Read more on the EHJ
@ESC_Journals
@escardio
#EHJ
#cardiotwitter
4
61
172
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases . Read now in EHJ
#cardiotwitter
@ESC_Journals
@escardio
1
72
169
Great debate just published in
#EHJ
: all patients with asymptomatic severe aortic stenosis need valve replacement.
#aorticstenosis
@escardio
@ESC_Journals
0
79
170
Aortic stenosis or valvular aortic stenosis is commonly encountered in homozygous familial hypercholesterolaemia (HoFH). New paper provides original insights.
2
49
171
Heart failure with preserved ejection fraction is associated with increased morbidity and mortality in patients with normal natriuretic peptide levels.
#heartfailure
#HFpEF
#cardiotwitter
@ESC_Journals
@escardio
3
47
170
Early invasive coronary angiography and acute ischaemic heart failure outcomes.
#HF
#ischaemia
#CAD
#revascularization
#death
#outcome
#cardiotwitter
@escardio
@ESC_Journals
0
62
169
May I just reduce the number of cigarettes? New study shows this is not enough! Smoking cessation, but not reduction, was associated with cardiovascular disease incidence drop.
#smoke
,
#cigarettes
,
#MI
,
#cardiotwitter
,
@ESC_Journals
,
@escardio
.
2
73
170